Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01976260 · ClinicalTrials.gov registry record · Phase 2

A Pilot Study Testing Fractional Radiofrequency Versus Fractional Photothermolysis for the Treatment of Acne Scars

A Phase 2 study of Cicatrix, sponsored by Northwestern University.

Active
Registry status
Phase 2
Development phase
16
Enrollment target
1
Study location

NCT01976260 is a Phase 2 study of Cicatrix that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 16 participants, below the 34-participant average among 4 other Cicatrix trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01976260, a Phase 2 study of Cicatrix, is active but no longer recruiting, sponsored by Northwestern University.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the effectiveness of the ePrime fractional radiofrequency system to the 1550-nm fractional photothermolysis system (Fraxel) in the ability to improve acne scar appearance.

Conditions Studied

Interventions

  • DEVICE Fractional Radiofrequency
  • DEVICE 1550-nm Fractional Photothermolysis

Study Locations (1)

Illinois

  • Northwestern University Department of Dermatology - Chicago

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2013-10
Est. Completion 2025-12
Phase Phase 2

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT01976260

The ClinicalTrials.gov registry entry for NCT01976260 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 34-participant average among 4 other Cicatrix trials with a reported enrollment target (53% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cicatrix appearing as the primary indexed condition, and to 2 interventions - of which Fractional Radiofrequency is the first listed.

NCT01976260 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT01976260 about?

NCT01976260 is a clinical study titled "A Pilot Study Testing Fractional Radiofrequency Versus Fractional Photothermolysis for the Treatment of Acne Scars". The purpose of this study is to compare the effectiveness of the ePrime fractional radiofrequency system to the 1550-nm fractional photothermolysis system (Fraxel) in the ability to improve acne scar appearance.

What is the current status of trial NCT01976260?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2013-10. Estimated completion is 2025-12.

What conditions does trial NCT01976260 study?

This clinical trial studies the following conditions: Cicatrix.

What interventions are being tested in trial NCT01976260?

The interventions under investigation include: Fractional Radiofrequency (DEVICE), 1550-nm Fractional Photothermolysis (DEVICE).

Who is sponsoring clinical trial NCT01976260?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01976260 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cicatrix

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.